Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

In-Vitro and in-Vivo Synergistic Effect of Melphalan and Dual DNA Repair Inhibition in Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 3301.

https://doi.org/10.1182/blood.V128.22.3301.3301

Published: 2016

Journal Articles

Cytopenia of Unknown Cause Post Allogeneic Stem Cell Transplant As a Predictor of Clinical Outcome

Annie L. Oh, MD, Krishna Ghimire, MD, Nandini Kalakota, MD, Karen Sweiss, PharmD, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2016) 128 (22): 5761.

https://doi.org/10.1182/blood.V128.22.5761.5761

Published: 2016

Journal Articles

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Dolores Mahmud, PhD, Shrihari S. Kadkol, MD PhD, Annie L. Oh, MD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4276.

https://doi.org/10.1182/blood.V128.22.4276.4276

Published: 2016

Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4646.

https://doi.org/10.1182/blood.V128.22.4646.4646

Published: 2016

Journal Articles

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Annie L. Oh, MD, Dolores Mahmud, PhD, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Nadim Mahmud, MD PhD, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2015) 126 (23): 4271.

https://doi.org/10.1182/blood.V126.23.4271.4271

Published: 2015

Journal Articles

Melphalan 200 Mg/m2 in Patients with Renal Impairment Is Associated with Increased Short Term Toxicity but Improved Response and Longer Treatment-Free Survival

Karen Sweiss, PharmD, Katie Culos, PharmD, Seema Patel, PharmD, Annie L. Oh, MD, Damiano Rondelli, MD, Pritesh R. Patel, MB, ChB

Blood (2015) 126 (23): 1998.

https://doi.org/10.1182/blood.V126.23.1998.1998

Published: 2015

Journal Articles

Dual DNA Damage Repair Inhibition Synergizes with Alkylator Chemotherapy for Myeloma and Acute Leukemia

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Annie L. Oh, MD, Damiano Rondelli, MD

Blood (2015) 126 (23): 2053.

https://doi.org/10.1182/blood.V126.23.2053.2053

Published: 2015

Journal Articles

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Santosh L. Saraf, MD, Annie L. Oh, MD, Dolores Mahmud, PhD, Pritesh R. Patel, MB, ChB, Karen Sweiss, PharmD, Matthew Koshy, MD, Sally Campbell-Lee, MD, Michel Gowhari, DO, Johara Hassan, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Lewis L. Hsu, MD PhD, Nadim Mahmud, MD PhD, Dennis J Levinson, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2014) 124 (21): 2703.

https://doi.org/10.1182/blood.V124.21.2703.2703

Published: 2014

Journal Articles

Synergistic Cytotoxic Effect Of The PARP Inhibitor ABT888 and Busulfan In Acute Leukemia Cell Lines

Pritesh R. Patel, MB, ChB, Dolores Mahmud, Ph.D., Damiano Rondelli, MD

Blood (2013) 122 (21): 4936.

https://doi.org/10.1182/blood.V122.21.4936.4936

Published: 2013

Journal Articles

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Annie L. Oh, MD, Dolores Mahmud, Ph.D., Benedetta Nicolini, Ph.D., Nadim Mahmud, MD, PhD, Elisa Bonetti, BS, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2013) 122 (21): 1999.

https://doi.org/10.1182/blood.V122.21.1999.1999

Published: 2013

Journal Articles

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Nadim Mahmud, MD, PhD, David Peace, MD, John G. Quigley, MD, Santosh L. Saraf, MD, Enzo DeMasi, MD, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3285.

https://doi.org/10.1182/blood.V122.21.3285.3285

Published: 2013

Journal Articles

Genomic Signature Predicts Resistance To Busulfan In AML Cell Lines

Pritesh R. Patel, MB, ChB, Dolores Mahmud, Ph.D., Wei Zhang, PhD, Joe GN Garcia, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3850.

https://doi.org/10.1182/blood.V122.21.3850.3850

Published: 2013

Journal Articles

Conjunctival Biopsy to Guide Treatment of Chronic Ocular Gvhd

Pritesh R. Patel, MB, ChB, Sonal Ghandi, MD, Snehal Sonawane, MD, Sapna Tibrewal, MD, Saumad Jassim, MD, Sujata Gaitonde, MD, Santosh L Saraf, MD, Sandeep Jain, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 4491.

https://doi.org/10.1182/blood.V120.21.4491.4491

Published: 2012

Journal Articles

Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Annie L. Oh, MD, Pritesh R. Patel, MB, ChB, Santosh Saraf, MD, Karen Sweiss, PharmD, David Peace, MD, John G. Quigley, MD, Nadim Mahmud, MD, PhD, Steven Dudek, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 4474.

https://doi.org/10.1182/blood.V120.21.4474.4474

Published: 2012

Journal Articles

Role of Ethnicity in Clinical Outcomes of Patients with Ph-Negative Myeloproliferative Neoplasms

Santosh Saraf, MD, Ardaman Shergill, MD, Pritesh R. Patel, MB, ChB, John G. Quigley, MD, David Peace, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 2076.

https://doi.org/10.1182/blood.V120.21.2076.2076

Published: 2012

Journal Articles

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Santosh Saraf, MD, Pritesh R. Patel, MB, ChB, Howard Ozer, MD, PhD, David Peace, MD, Sangeetha Nimmagadda, MD, John G. Quigley, MD, Damiano Rondelli, MD

Blood (2011) 118 (21): 4213.

https://doi.org/10.1182/blood.V118.21.4213.4213

Published: 2011

Journal Articles

Anti-Leukemic Activity Is Increased with Low Dose Busulfan and Irradiation: A Preclinical Model

Pritesh R. Patel, MB, ChB, Dolores Mahmud, PhD, Wei Zhang, PhD, Tong Zhou, PhD, Nadim Mahmud, MD, PhD, Ralph R Weichselbaum, MD, Joe GN Garcia, MD, Damiano Rondelli, MD

Blood (2011) 118 (21): 4696.

https://doi.org/10.1182/blood.V118.21.4696.4696

Published: 2011

Journal Articles

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Pritesh R. Patel, MB, ChB, Bulent Aydogan, PhD, Damiano Rondelli, MD

Blood (2010) 116 (21): 4526.

https://doi.org/10.1182/blood.V116.21.4526.4526

Published: 2010

Journal Articles

Retrospective Review of Hypercoagulability in Minority Populations at an Inner City Hospital’s General Hematology Clinic.

Pritesh R. Patel, MB, ChB, Manila Gaddh, MD, Sunita Nathan, MD, Griza Decebal, MD, Rosalind Catchatourian, MD, Margaret C. Telfer, MD

Blood (2007) 110 (11): 3973.

https://doi.org/10.1182/blood.V110.11.3973.3973

Published: 2007

NARROW

In-Vitro and in-Vivo Synergistic Effect of Melphalan and Dual DNA Repair Inhibition in Multiple Myeloma

Cytopenia of Unknown Cause Post Allogeneic Stem Cell Transplant As a Predictor of Clinical Outcome

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Melphalan 200 Mg/m2 in Patients with Renal Impairment Is Associated with Increased Short Term Toxicity but Improved Response and Longer Treatment-Free Survival

Dual DNA Damage Repair Inhibition Synergizes with Alkylator Chemotherapy for Myeloma and Acute Leukemia

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Synergistic Cytotoxic Effect Of The PARP Inhibitor ABT888 and Busulfan In Acute Leukemia Cell Lines

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Genomic Signature Predicts Resistance To Busulfan In AML Cell Lines

Conjunctival Biopsy to Guide Treatment of Chronic Ocular Gvhd

Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Role of Ethnicity in Clinical Outcomes of Patients with Ph-Negative Myeloproliferative Neoplasms

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Anti-Leukemic Activity Is Increased with Low Dose Busulfan and Irradiation: A Preclinical Model

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Retrospective Review of Hypercoagulability in Minority Populations at an Inner City Hospital’s General Hematology Clinic.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only